AMRUTANJAN HEALTH CARE
|
AMRUTANJAN HEALTH CARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.63 | 22.99 | 20.93 | 8.58 | 8.39 |
| CEPS(Rs) | 15.41 | 24.28 | 22.19 | 10.07 | 9.50 |
| DPS(Rs) | 4.60 | 4.60 | 4.20 | 2.10 | 2.15 |
| Book NAV/Share(Rs) | 99.12 | 90.49 | 73.53 | 54.54 | 49.86 |
| Tax Rate(%) | 25.74 | 25.82 | 25.29 | 27.20 | 29.32 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.73 | 19.11 | 20.20 | 11.79 | 12.21 |
| EBIT Margin(%) | 14.19 | 22.46 | 24.79 | 13.31 | 13.77 |
| Pre Tax Margin(%) | 14.13 | 22.32 | 24.61 | 13.18 | 13.69 |
| PAT Margin (%) | 10.49 | 16.56 | 18.38 | 9.59 | 9.67 |
| Cash Profit Margin (%) | 11.87 | 17.49 | 19.49 | 11.26 | 10.96 |
| Performance Ratios | |||||
| ROA(%) | 11.32 | 21.78 | 25.94 | 13.05 | 14.18 |
| ROE(%) | 14.37 | 28.03 | 32.69 | 16.44 | 17.87 |
| ROCE(%) | 19.38 | 37.93 | 44.00 | 22.80 | 25.43 |
| Asset Turnover(x) | 1.08 | 1.32 | 1.41 | 1.36 | 1.47 |
| Sales/Fixed Asset(x) | 6.26 | 9.31 | 8.50 | 7.09 | 7.44 |
| Working Capital/Sales(x) | 1.93 | 2.06 | 1.95 | 3.01 | 2.45 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.16 | 0.11 | 0.12 | 0.14 | 0.13 |
| Receivable days | 34.26 | 25.15 | 24.19 | 41.46 | 43.86 |
| Inventory Days | 26.36 | 19.54 | 22.58 | 26.73 | 17.96 |
| Payable days | 108.19 | 102.26 | 93.75 | 95.43 | 86.35 |
| Valuation Parameters | |||||
| PER(x) | 42.19 | 34.53 | 27.15 | 38.45 | 37.05 |
| PCE(x) | 37.31 | 32.69 | 25.61 | 32.76 | 32.71 |
| Price/Book(x) | 5.80 | 8.77 | 7.73 | 6.05 | 6.23 |
| Yield(%) | 0.80 | 0.58 | 0.74 | 0.64 | 0.69 |
| EV/Net Sales(x) | 4.24 | 5.50 | 4.57 | 3.55 | 3.26 |
| EV/Core EBITDA(x) | 27.26 | 23.51 | 17.66 | 23.71 | 21.68 |
| EV/EBIT(x) | 29.89 | 24.49 | 18.45 | 26.68 | 23.71 |
| EV/CE(x) | 4.50 | 6.45 | 5.62 | 4.62 | 4.51 |
| M Cap / Sales | 4.43 | 5.72 | 4.99 | 3.69 | 3.58 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -6.46 | 21.93 | 27.29 | 3.20 | 15.17 |
| Core EBITDA Growth(%) | -37.78 | 10.20 | 120.08 | 2.65 | 5.44 |
| EBIT Growth(%) | -40.91 | 10.50 | 137.11 | -0.27 | 4.87 |
| PAT Growth(%) | -40.71 | 9.80 | 143.95 | 2.32 | 22.27 |
| EPS Growth(%) | -40.71 | 9.80 | 143.95 | 2.32 | -38.86 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 4.12 | 3.55 | 4.28 | 3.22 | 3.87 |
| Quick Ratio(x) | 3.66 | 3.21 | 3.94 | 2.61 | 3.46 |
| Interest Cover(x) | 241.99 | 156.66 | 139.35 | 102.57 | 172.19 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of AMRUTANJAN HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMRUTANJAN HEALTH CARE | ₹1,993.1 Cr | 8.1% | 13.7% | 11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹364,831.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
| CIPLA | ₹113,471.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,713.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹101,960.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,687.8 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics | |
AMRUTANJAN HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMRUTANJAN HEALTH CARE | 8.1% |
13.7% |
11.1% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
